Literature DB >> 4758061

Trimethoprim-sulfamethoxazole. Summary and comments on the conference.

M Finland, E H Kass.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4758061     DOI： 10.1093/infdis/128.supplement_3.s792

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  6 in total

Review 1.  Principles of combination therapy.

Authors:  S Levin; A A Harris
Journal:  Bull N Y Acad Med       Date:  1975-10

2.  Infections caused by gram-negative pathogens: new clinical considerations.

Authors:  H C Neu
Journal:  Bull N Y Acad Med       Date:  1975-10

3.  In vivo synergy between 6 beta-amidinopenicillanic acid derivatives and other antibiotics.

Authors:  E Grunberg; R Cleeland; G Beskid; W F DeLorenzo
Journal:  Antimicrob Agents Chemother       Date:  1976-04       Impact factor: 5.191

4.  In vitro susceptibility of Haemophilus influenzae to trimethoprim-sulfamethoxazole.

Authors:  L A Kirven; C Thornsberry
Journal:  Antimicrob Agents Chemother       Date:  1974-12       Impact factor: 5.191

5.  Antimycobacterial activities of 2,4-diamino-5-deazapteridine derivatives and effects on mycobacterial dihydrofolate reductase.

Authors:  W J Suling; L E Seitz; V Pathak; L Westbrook; E W Barrow; S Zywno-Van-Ginkel; R C Reynolds; J R Piper; W W Barrow
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

6.  Development of antibacterial compounds that constrain evolutionary pathways to resistance.

Authors:  Yanmin Zhang; Sourav Chowdhury; João V Rodrigues; Eugene Shakhnovich
Journal:  Elife       Date:  2021-07-19       Impact factor: 8.140
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.